Article Text

PDF
Concise report
Dual energy computed tomography in tophaceous gout
  1. H K Choi1,2,
  2. A M Al-Arfaj1,
  3. A Eftekhari3,
  4. P L Munk3,
  5. K Shojania1,2,
  6. G Reid1,
  7. S Nicolaou3
  1. 1
    Division of Rheumatology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada
  2. 2
    Arthritis Research Centre of Canada, Vancouver, Canada
  3. 3
    Radiology Department, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada
  1. Correspondence to Dr H K Choi, Division of Rheumatology, Department of Medicine, University of British Columbia, Arthritis Research Centre of Canada, 895 West 10th Avenue, Vancouver, BC V5Z 1L7, Canada; hchoi{at}arthritisresearch.ca

Abstract

Objective: To evaluate the potential utility of a dual energy CT (DECT) scan in assessing urate deposits among patients with tophaceous gout, and obtain computerised quantification of tophus volume in peripheral joints.

Methods: 20 consecutive patients with tophaceous gout and 10 control patients with other arthritic conditions were included. DECT scans were performed using a renal stone colour-coding protocol that specifically assessed the chemical composition of the material (ie, urate coloured in red, calcium coloured in blue). An automated volumetric assessment of DECT was used to measure the volume of urate deposits in all peripheral joint areas.

Results: All 20 patients with gout showed red colour-coded urate deposits on their DECT scans, whereas none of 10 controls showed urate deposits. DECT scans revealed a total of 440 areas of urate deposition in 20 patients, whereas physical examination showed 111 areas of urate deposition (mean 22 vs 6 per patient, respectively, p<0.001). Total urate volume in a given patient ranged from 0.63 cm3 to 249.13 cm3, with a mean of 40.20 cm3.

Conclusions: DECT scans can produce obvious colour displays for urate deposits and help to identify subclinical tophus deposits. Furthermore, tophus volume can be measured by DECT scans through an automated volume estimation procedure.

Statistics from Altmetric.com

Footnotes

  • Funding HKC holds the Mary Pack Arthritis Society of Canada Chair in Rheumatology and has received research funding from TAP Pharmaceuticals for other research projects. In addition, HKC has received honoraria from and serves as a consultant to TAP Pharmaceuticals and Savient.

  • Competing interests None.

  • Ethics approval Approval from Vancouver General Hospital Ethics Committee.

  • ▸ An additional table and figure are published online only at http://ard.bmj.com/content/vol68/issue10

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.